2-100975541-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002518.4(NPAS2):c.1366G>A(p.Gly456Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000385 in 1,612,170 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002518.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NPAS2 | NM_002518.4 | c.1366G>A | p.Gly456Arg | missense_variant | 14/21 | ENST00000335681.10 | |
NPAS2-AS1 | NR_110213.1 | n.447-128C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NPAS2 | ENST00000335681.10 | c.1366G>A | p.Gly456Arg | missense_variant | 14/21 | 1 | NM_002518.4 | P1 | |
NPAS2-AS1 | ENST00000652285.1 | n.468C>T | non_coding_transcript_exon_variant | 2/6 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000522 AC: 13AN: 249144Hom.: 0 AF XY: 0.0000743 AC XY: 10AN XY: 134680
GnomAD4 exome AF: 0.0000288 AC: 42AN: 1459894Hom.: 0 Cov.: 30 AF XY: 0.0000330 AC XY: 24AN XY: 726180
GnomAD4 genome AF: 0.000131 AC: 20AN: 152276Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74450
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 02, 2022 | The c.1366G>A (p.G456R) alteration is located in exon 14 (coding exon 13) of the NPAS2 gene. This alteration results from a G to A substitution at nucleotide position 1366, causing the glycine (G) at amino acid position 456 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at